Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections.

PloS one - 1 Jan 2015

Marton Matthew J, McNamara Andrew R, Nikoloff D Michele, Nakao Aki, Cheng Jonathan

Abstract excerpt

The p53 tumor suppressor gene (TP53) is reported to be mutated in nearly half of all tumors and plays a central role in genome integrity. Detection of mutations in p53 can be accomplished by many assays, including the AmpliChip p53 Research Test. The AmpliChip p53 Research Test has been successfully used to determine p53 status in hematologic malignancies and fresh frozen solid tissues but there are few reports...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA
Share to Formaldehyde
Share to Oligonucleotide Array Sequence Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Paraffin Embedding

Share to Reproducibility of Results

Share to Tissue Fixation

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 26125596
DOI: 10.1371/journal.pone.0131497
PMCID: PMC4488390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections.PMID 26125596Read ↗

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high-grade serous ovarian carcinoma.Semantic proximity Read ↗

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR methodSemantic proximity Read ↗

High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation calling.Semantic proximity Read ↗

IHC p53 Performance in NordiQC: Recalibration of IHC Assays is Needed.Semantic proximity Read ↗

Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors.Semantic proximity Read ↗

Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.Semantic proximity Read ↗

Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.Semantic proximity Read ↗

Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual TP53 TranscriptsSemantic proximity Read ↗

Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.Semantic proximity Read ↗

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies.Semantic proximity Read ↗

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.Semantic proximity Read ↗

Optimized p53 immunohistochemistry is an accurate predictor of <i>TP53</i> mutation in ovarian carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.